Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

24
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
24
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

24
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
24

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Global epidemiology of thyroid cancer: trends in incidence, mortality, and DALYs from 1990 to 2021.

Open medicine (Warsaw, Poland)·2026
Same author

Risk Stratification for Cephalosporin-Induced Thrombocytopenia: Development and Validation of a Multidimensional Predictive Model in Older Adults.

Risk management and healthcare policy·2025
Same author

Predictive Model of Internal Bleeding in Elderly Aspirin Users Using XGBoost Machine Learning.

Risk management and healthcare policy·2024
Same author

A Practical Nomogram for Predicting the Bleeding Risk in Patients with a History of Myocardial Infarction Treating with Aspirin.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2024
Same author

Macrophage in liver Fibrosis: Identities and mechanisms.

International immunopharmacology·2023
Same author

Ensemble machine learning algorithm for predicting acute kidney injury in patients admitted to the neurointensive care unit following brain surgery.

Scientific reports·2023

相关实验视频

Updated: Feb 20, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.9K

开发和验证可解释的机器学习模型,用于预测第三代脑胺治疗期间的血小板血风险.

Kailei Du1, Maofeng Wang2, Ping Yu3

  • 1Intensive Care Medicine, Affiliated Dongyang Hospital, Wenzhou Medical University, Dongyang, Zhejiang, 322100, People's Republic of China.

Journal of blood medicine
|February 19, 2026
PubMed
概括

这项研究开发了一种可解释的机器学习模型,用于预测第三代氨酸治疗期间的血栓塞血症风险. 该模型准确识别风险患者,改善严重感染的治疗决策.

关键词:
在XGBoost中使用.机器学习是机器学习.风险预测风险预测第三代化素是什么?血小板细胞血症的发生.

更多相关视频

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

8.2K

相关实验视频

Last Updated: Feb 20, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.9K
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

8.2K

科学领域:

  • 药理学 药理学是指药理学的学科.
  • 医疗信息学 医疗信息学
  • 机器学习 机器学习

背景情况:

  • 第三代头素对严重感染至关重要,但可能导致血栓塞血症,使治疗复杂化.
  • 目前用于预测这种风险的工具缺乏准确性和临床解释性.
  • 需要可靠的方法来分层对接受黄素的患者的血栓塞瘤风险.

研究的目的:

  • 开发和验证一种可解释的机器学习 (ML) 模型,用于预测第三代脑类药物治疗的患者的血小板血风险.
  • 通过提供准确和可理解的风险分层来增强临床决策.
  • 为了确定这一患者群体中血栓塞瘤的关键预测因子.

主要方法:

  • 分析了25707名成年患者接受第三代头素的回顾性队列.
  • 机器学习算法 (XGBoost,随机森林,LightGBM) 被训练和测试,使用ROC-AUC和Brier评分来评估性能.
  • 用SHAP分析来分析模型的解释性,确定关键的预测因素.

主要成果:

  • 该XGBoost模型实现了卓越的性能,其AUC为0.858和Brier分数为0.0088.
  • 关键预测因素包括基线血小板计数,红细胞计数,肌素,每日使用频率和性别.
  • 恶性瘤增加了风险,而女性性别显示有保护作用.

结论:

  • 成功开发了一种可解释的ML框架,用于精确预测在氨酸治疗期间的血栓塞血症风险.
  • 该模型平衡了高算法性能与临床可操作性,帮助治疗决策.
  • 这些发现为管理与黄治疗相关的潜在不良事件提供了有价值的工具.